These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2828894)

  • 81. Scale-up and optimization of culture conditions of a human heterohybridoma producing serotype-specific antibodies to Pseudomonas aeruginosa.
    Schürch U; Cryz SJ; Lang AB
    Appl Microbiol Biotechnol; 1992 Jul; 37(4):446-50. PubMed ID: 1368466
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Characterization of mouse monoclonal antibodies directed against Pseudomonas aeruginosa lipopolysaccharides.
    Sadoff JC; Wright DC; Futrovsky S; Sidberry H; Collins H; Kaufmann B
    Antibiot Chemother (1971); 1985; 36():134-46. PubMed ID: 3923911
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Serological immune response against major secretory proteins expressed by Pseudomonas aeruginosa upon intratracheal infection in mice.
    Kinoshita M; Sawa T
    Respir Investig; 2022 Mar; 60(2):318-321. PubMed ID: 35031257
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
    Que YA; Lazar H; Wolff M; François B; Laterre PF; Mercier E; Garbino J; Pagani JL; Revelly JP; Mus E; Perez A; Tamm M; Rouby JJ; Lu Q; Chastre J; Eggimann P
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1861-7. PubMed ID: 24859907
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Detection of mycoplasma contamination lymphoblastoid cell lines by monoclonal antibodies.
    Radka SF; Hester DM; Polak-Vogelzang AA; Bolhuis RL
    Hum Immunol; 1984 Feb; 9(2):111-6. PubMed ID: 6698819
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Differential growth characteristics and immunogenicity of tight and coasting temperature-sensitive mutants of Pseudomonas aeruginosa.
    Morris Hooke A; Sordelli DO; Cerquetti MC; Bellanti JA
    Infect Immun; 1987 Jan; 55(1):99-103. PubMed ID: 3098688
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide.
    Tout NL; Lam JS
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):147-55. PubMed ID: 9067648
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide.
    Terashima M; Uezumi I; Tomio T; Kato M; Irie K; Okuda T; Yokota S; Noguchi H
    Infect Immun; 1991 Jan; 59(1):1-6. PubMed ID: 1898896
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa.
    Zweerink HJ; Gammon MC; Hutchison CF; Jackson JJ; Lombardo D; Miner KM; Puckett JM; Sewell TJ; Sigal NH
    Infect Immun; 1988 Aug; 56(8):1873-9. PubMed ID: 3135264
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice.
    O'Oka H; Chonan E; Mizutani K; Fukuda T; Kuroiwa Y; Ono Y; Shigeta S
    Microbiol Immunol; 1992; 36(12):1305-16. PubMed ID: 1287405
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Production and some properties of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa.
    Yoshida K; Kimura F; Uchida K; Kawaharajo K; Koizumi N; Nakajima S; Nagaoka K
    J Pharmacobiodyn; 1989 Jul; 12(7):398-404. PubMed ID: 2512385
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Human monoclonal antibodies to Pseudomonas aeruginosa produced by EBV-transformed cells.
    Suzuki H; Okubo Y; Moriyama M; Sasaki M; Matsumoto Y; Hozumi T
    Microbiol Immunol; 1987; 31(10):959-66. PubMed ID: 2828894
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.